Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma
- DOI
- 10.1186/s12967-026-07865-0
- Published
- 2026-02-26
- Container
- Journal of Translational Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12967-026-07865-0,
title = {Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma},
author = {Zi-Lin Li and Sachin Kumar and San-Nan Yang and Tung-Cheng Chang and Lin-Yi Huang and Ching-Chung Ko and Yung-Ning Yang and Chih-Jung Yao and Dana R. Crawford and Fabio Gionfra and Dahlak Daniel Solomon and Yung-Kuo Lee and Do Thi Minh Xuan and Hui-Ru Lin and Chih-Yang Wang and Amruta Aher and Nandana Bayu Abhista and Ya-Jung Shih and Sheng-Yang Lee and Haw-Ming Huang and Hung-Yun Lin and Kuan Wang and Jaqueline Whang-Peng},
year = {2026},
journal = {Journal of Translational Medicine},
doi = {10.1186/s12967-026-07865-0},
url = {https://doi.org/10.1186/s12967-026-07865-0}
}RIS
TY - JOUR TI - Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma AU - Zi-Lin Li AU - Sachin Kumar AU - San-Nan Yang AU - Tung-Cheng Chang AU - Lin-Yi Huang AU - Ching-Chung Ko AU - Yung-Ning Yang AU - Chih-Jung Yao AU - Dana R. Crawford AU - Fabio Gionfra AU - Dahlak Daniel Solomon AU - Yung-Kuo Lee AU - Do Thi Minh Xuan AU - Hui-Ru Lin AU - Chih-Yang Wang AU - Amruta Aher AU - Nandana Bayu Abhista AU - Ya-Jung Shih AU - Sheng-Yang Lee AU - Haw-Ming Huang AU - Hung-Yun Lin AU - Kuan Wang AU - Jaqueline Whang-Peng PY - 2026 JO - Journal of Translational Medicine DO - 10.1186/s12967-026-07865-0 UR - https://doi.org/10.1186/s12967-026-07865-0 ER -
APA
Li, Z., Kumar, S., Yang, S., Chang, T., Huang, L., Ko, C., Yang, Y., Yao, C., Crawford, D. R., Gionfra, F., Solomon, D. D., Lee, Y., Xuan, D. T. M., Lin, H., Wang, C., Aher, A., Abhista, N. B., Shih, Y., Lee, S., Huang, H., Lin, H., Wang, K., & Whang-Peng, J. (2026). Integrin αvβ3-dependent pathogenic effect and therapeutic effects of DL-N2 combined with EGFR inhibitors in pancreatic adenocarcinoma. Journal of Translational Medicine. https://doi.org/10.1186/s12967-026-07865-0
Source records
- crossref · retrieved 2026-11-10T14:07:19.522Z